4.7 Article

Prevalence, sequence type, and quinolone resistance of Neisseria lactamica carried in children younger than 15 years in Shanghai, China

Journal

JOURNAL OF INFECTION
Volume 80, Issue 1, Pages 61-68

Publisher

W B SAUNDERS CO LTD
DOI: 10.1016/j.jinf.2019.08.020

Keywords

Neisseria lactamica; Quinolone resistance; Multilocus sequence typing (MLST); gyrA; parC; Horizontal gene transfer

Funding

  1. National Natural Science Foundation of China [81601801]
  2. Shanghai Rising-Star Program [17QA1403100]
  3. Shanghai Medical Health Plan for Outstanding Young Talents [2017YQ039]
  4. Natural Science Foundation of Shanghai [16ZR1433300]

Ask authors/readers for more resources

Objective: Neisseria lactamica has an important influence on carriage and antimicrobial susceptibility of N. meningitidis, a major pathogen of septicemia and meningitis. In China, quinolone resistance is highly prevalent in N. meningitidis but unknown in N. lactamica. This study investigates the carriage rate, sequence type, and ciprofloxacin resistance of N. lactamica in children in China. Methods: During 2014-2016, throat swabs were collected from 2,239 children in Shanghai. The ciprofloxacin minimum inhibitory concentrations of the isolates were determined by the agar dilution method. Results: The overall carriage rate of N. lactamica was higher (8.9%) than that of N. meningitidis (0.9%) and peaked at two years (37.1%). The resistance frequency of N. lactamica to ciprofloxacin was 98.5% (197/200). There were 65 sequence types (STs). Clonal complex (cc) 640 (45.5%) dominated, while ST-14031 was predominant (37%, 74/200). All isolates possessed a GyrA mutation; 17 isolates (8.5%) harbored additionally a ParC mutation. Assigned to 39 different alleles, the gyrA sequences from these N. lactamica isolates formed an N. lactamica cluster, which also included eight alleles from N. meningitidis. Conclusion: The N. lactamica isolates in China showed distinct characteristics with lower genetic diversity and a much higher prevalence of quinolone resistance than in other countries. (C) 2019 The British Infection Association. Published by Elsevier Ltd. All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available